Katie Adams

Healthcare providers and researchers are warning that HHS Secretary Robert F. Kennedy Jr.’s firing of two USPSTF vice chairs could politicize one of the nation’s most influential preventive care panels.

Three health systems — Mount Sinai, Michigan Medicine and the University of Kansas Health System — are suing CVS Health, alleging its pharmacy benefit manager diverted roughly $250 million in savings from the 340B program through “spread pricing” between 2020 and 2025.

A new UPMC report found that while most health systems now offer precision medicine programs, many still face challenges scaling them due to reimbursement, data integration and patient engagement issues. Health system leaders say the field’s future depends on embedding genomics into routine care, as well as proving its clinical and financial value.

A new UPMC report found that while most health systems now offer precision medicine programs, many still face challenges scaling them due to reimbursement, data integration and patient engagement issues.

Oura has filed for an IPO as it looks to build on its evolution from a sleep-focused wearable startup into a broader healthcare player.

Bayesian Health became the first company to receive FDA clearance for a continuous AI-powered sepsis monitoring system. The clearance follows years of clinical validation studies and real-world deployments across multiple health systems.

CMS finalized a new rule aimed at streamlining the No Surprises Act’s overwhelmed arbitration system. Provider groups largely welcomed the reforms — though some industry leaders said additional changes are still needed to address alleged misuse and improve transparency.

May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Abridge, Highmark Health and Merck named new executives. There were also layoffs at organizations including Innovaccer, Intermountain Health and Novartis.

Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations.

Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom's over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations.